Sarcopenia and low muscle radiodensity associate with impaired FEV
Allogeneic haematopoietic transplantation
Forced expiratory volume
Muscle radiodensity
Sarcopenia
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
14
08
2019
revised:
10
04
2020
accepted:
28
05
2020
pubmed:
31
7
2020
medline:
29
10
2021
entrez:
31
7
2020
Statut:
ppublish
Résumé
Quantification of skeletal muscle using computed tomography (CT) is accessible using cancer patients' standard oncologic images. Reduced muscle mass may be related to reduced respiratory muscle strength; however, the impact of this on lung functional parameters is not characterized in adult allogeneic haematopoietic stem cell transplant (alloHCT) recipients. A consecutive retrospective series (n = 296) of patients who had alloHCT at a comprehensive cancer centre between March 2005 and April 2015 were included. Pre-transplant CT scans were used to quantify skeletal muscle and adipose tissue at the fourth thoracic (T4) and/or third lumbar (L3) level. Tumour and patient characteristics were recorded, including forced expiratory volume in 1 second (FEV A total of 296 patients (♂n = 161; ♀n = 135) were included, all of whom had chest CT as part of standard care; a subset of these (n = 215, 72.6%) also had abdominal CT. Diagnoses were non-Hodgkins lymphoma (n = 165), acute myeloid leukaemia (n = 66), Hodgkin's disease (n = 14), acute lymphocytic leukaemia (n = 14), myelodysplastic syndromes (n = 18), and other (n = 19). In multivariable linear regression adjusted for sex (P < 0.0001), age (P < 0.0001), haematopoietic cell transplantation-specific co-morbidity index (P = 0.010), and parameters of pulmonary function testing (defined by spirometry, P < 0.0001), both T4 muscle index [β 0.127 (95% confidence interval 0.019; 0.252), P < 0.0001] and T4 muscle radiodensity [β 0.132 (95% confidence interval 0.087; 0.505), P = 0.006] were independently associated with FEV Lumbar or thoracic CT images are useful for body composition assessment in this population and reveal high rates of sarcopenia, similar to those reported in very elderly patients. Reduced muscle mass and radiodensity associate with impaired FEV
Sections du résumé
BACKGROUND
Quantification of skeletal muscle using computed tomography (CT) is accessible using cancer patients' standard oncologic images. Reduced muscle mass may be related to reduced respiratory muscle strength; however, the impact of this on lung functional parameters is not characterized in adult allogeneic haematopoietic stem cell transplant (alloHCT) recipients.
METHODS
A consecutive retrospective series (n = 296) of patients who had alloHCT at a comprehensive cancer centre between March 2005 and April 2015 were included. Pre-transplant CT scans were used to quantify skeletal muscle and adipose tissue at the fourth thoracic (T4) and/or third lumbar (L3) level. Tumour and patient characteristics were recorded, including forced expiratory volume in 1 second (FEV
RESULTS
A total of 296 patients (♂n = 161; ♀n = 135) were included, all of whom had chest CT as part of standard care; a subset of these (n = 215, 72.6%) also had abdominal CT. Diagnoses were non-Hodgkins lymphoma (n = 165), acute myeloid leukaemia (n = 66), Hodgkin's disease (n = 14), acute lymphocytic leukaemia (n = 14), myelodysplastic syndromes (n = 18), and other (n = 19). In multivariable linear regression adjusted for sex (P < 0.0001), age (P < 0.0001), haematopoietic cell transplantation-specific co-morbidity index (P = 0.010), and parameters of pulmonary function testing (defined by spirometry, P < 0.0001), both T4 muscle index [β 0.127 (95% confidence interval 0.019; 0.252), P < 0.0001] and T4 muscle radiodensity [β 0.132 (95% confidence interval 0.087; 0.505), P = 0.006] were independently associated with FEV
CONCLUSIONS
Lumbar or thoracic CT images are useful for body composition assessment in this population and reveal high rates of sarcopenia, similar to those reported in very elderly patients. Reduced muscle mass and radiodensity associate with impaired FEV
Identifiants
pubmed: 32729255
doi: 10.1002/jcsm.12604
pmc: PMC7749567
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1570-1579Subventions
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : CIHR
Pays : Canada
Informations de copyright
© 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
Ann Surg Oncol. 2018 Sep;25(9):2669-2680
pubmed: 30006691
Am J Epidemiol. 1998 Apr 15;147(8):755-63
pubmed: 9554417
Ann Am Thorac Soc. 2016 Nov;13(11):1932-1939
pubmed: 27513368
Biol Blood Marrow Transplant. 2015 Aug;21(8):1479-87
pubmed: 25862591
Eur Respir J. 2017 Jan 3;49(1):
pubmed: 28049168
J Clin Oncol. 1998 Dec;16(12):3796-802
pubmed: 9850024
Sci Rep. 2018 Jul 27;8(1):11369
pubmed: 30054580
Blood. 2012 Aug 9;120(6):1327-33
pubmed: 22740454
PLoS One. 2015 Jun 01;10(6):e0127589
pubmed: 26030144
Blood. 2012 Jul 26;120(4):905-13
pubmed: 22709687
Clin Respir J. 2018 Mar;12(3):939-947
pubmed: 28054460
J Clin Oncol. 2017 Jan 20;35(3):306-313
pubmed: 27870568
Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S40-5
pubmed: 22226111
Bone Marrow Transplant. 2015 Jun;50(6):834-9
pubmed: 25798671
J Nutr Health Aging. 2009 Oct;13(8):724-8
pubmed: 19657557
J Clin Oncol. 2005 Jan 20;23(3):599-608
pubmed: 15659507
Biol Blood Marrow Transplant. 2013 Mar;19(3):429-34
pubmed: 23160006
Eur Urol Focus. 2018 Apr;4(3):420-434
pubmed: 28753824
Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):177-185
pubmed: 28848929
Front Physiol. 2012 Jul 11;3:260
pubmed: 22934016
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145
pubmed: 31661195
Biol Blood Marrow Transplant. 2018 Aug;24(8):1741-1747
pubmed: 29496561
Biol Blood Marrow Transplant. 2006 Jun;12(6):648-55
pubmed: 16737938
Semin Cell Dev Biol. 2016 Jun;54:2-10
pubmed: 26343952
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1570-1579
pubmed: 32729255
Eur J Cancer. 1996 Jun;32A(7):1135-41
pubmed: 8758243
Leuk Lymphoma. 2014 Apr;55(4):817-23
pubmed: 23781925
Can J Diet Pract Res. 2013 Summer;74(2):69-74
pubmed: 23750978
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):814-826
pubmed: 31094101
Liver Cancer. 2018 Mar;7(1):76-89
pubmed: 29662835
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Blood. 2005 Oct 15;106(8):2912-9
pubmed: 15994282
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):298-304
pubmed: 27897411
Bone Marrow Transplant. 2005 Mar;35(5):429-35
pubmed: 15654355
N Engl J Med. 2016 May 12;374(19):1811-21
pubmed: 27168432
J Clin Oncol. 2016 Oct 10;34(29):3544-3553
pubmed: 27573652
J Gerontol A Biol Sci Med Sci. 2011 Jul;66(7):801-8
pubmed: 21498841
J Med Assoc Thai. 2016 Apr;99(4):386-93
pubmed: 27396222
Cancer. 2008 May 1;112(9):1992-2001
pubmed: 18311781
Curr Res Transl Med. 2019 Aug;67(3):93-99
pubmed: 30583985
J Appl Physiol (1985). 1991 Aug;71(2):644-50
pubmed: 1938738
Biol Blood Marrow Transplant. 2000;6(5A):576-91
pubmed: 11071263
Biol Blood Marrow Transplant. 2015 Jul;21(7):1167-87
pubmed: 25838185
Lancet Oncol. 2008 Jul;9(7):629-35
pubmed: 18539529
N Engl J Med. 1995 Mar 2;332(9):556-61
pubmed: 7838189
Bone Marrow Transplant. 2006 Jul;38(2):101-9
pubmed: 16751786